This mouse monoclonal antibody was generated against a ΦX174 bacteriophage-derived ...

This human serum specimen contains polyclonal antibodies induced by natural infecti...

  3T3-J2 is a subclone of the original mouse embryonic fibroblast line; 3T3-Sw...

Vesicular stomatitis virus (VSV) is a widely studied prototype enveloped virus that...

The R28 cells were developed from E1A-NR.3 parental cell line through three rounds o...

Company Profile

Kerafast is a Boston-based life science company working to facilitate access to reagents developed by leading laboratories across the globe. Through an online platform, Kerafast provides rapid access to these novel reagents, helping remove traditional barriers to sharing biomaterials among researchers. Kerafast then returns a generous portion of every sale to the contributing scientists and their institutions, helping fuel the research of both providing and procuring laboratories. The mission is to create a global community of scientists sharing “reagents for the greater good” in order to advance their own research as well as scientific progress overall.

To achieve this mission, Kerafast has partnered with more than 140 prominent academic research institutions worldwide since its founding in 2011. More than 2,000 reagents are currently available via Kerafast's platform-and hundreds more products are added annually. To date, these reagents have been accessed and used by researchers in 52 different countries across six continents.

For more information, please visit

Contact Kerafast

27 Drydock Ave, 2nd Floor
Boston, MA 02210
Company Website

Request Info